A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

✍ Scribed by David Cameron; Michelle Casey; Michael Press; Deborah Lindquist; Tadeusz Pienkowski; C. Gilles Romieu; Stephen Chan; Agnieszka Jagiello-Gruszfeld; Bella Kaufman; John Crown; Arlene Chan; Mario Campone; Patrice Viens; Neville Davidson; Vera Gorbounova; Johannes Isaac Raats; Dimosthenis Skarlos; Beth Newstat; Debasish Roychowdhury; Paolo Paoletti; Cristina Oliva; Stephen Rubin; Steven Stein; Charles E. Geyer

• Publisher: Springer US
• Year: 2008
• Tongue: English
• Weight: 330 KB
• Volume: 112
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-007-9885-0